Introduction
Castleman's disease (angiofollicular lymph node hyperplasia) is often associated with systemic manifestations,1 although central nervous system involvement is unusual. We describe such a patient in whom pseudotumour cerebri occurred and in whom the degree of papilloedema fluctuated with disease activity.
Case report
A 40 year old West Indian woman was admitted in 1977 with severe headaches for 10 days, blurring of vision and a blackout, and was found to have bilateral papilloedema. An electroencephalogram, isotope brain scan and left carotid angiogram were normal. Lumbar puncture was normal apart from a raised pressure of 38 cm water. A diagnosis of pseudotumour cerebri was made; she was started on acetazolamide and cerebrospinal fluid was drained four times to reduce the pressure. In 1978, a fluorescein angiogram confirmed that intracranial pressure was still raised, although she was clinically asymptomatic with normal visual fields, and minimal residual disc swelling.
She was readmitted in 1979, still on acetazolamide, with a 6-month history of 22kg weight loss, malaise, lethargy, nausea, more frequent headaches and irregular menstruation. On examination she had a palpable liver edge and spleen, and widespread lymphadenopathy, and a chest X-ray showed bilateral pleural effusions with paratracheal and mediastinal lymphadenopathy. Peripheral nerve conduction studies confirmed a symptomless motor and sensory peripheral neuropathy. A radiological bone survey revealed sclerotic changes in three vertebral bodies and a lytic lesion in the left acetabulum, and electrophoresis of serum showed an IgG paraprotein band; other immunoglobulin levels were normal. However, histological appearances of biopsy specimens of bone marrow and of a sclerotic vertebra were both normal. Mild primary myxoedema and a low serum B12 level were found, but tests of gastrointestinal function and a computed tomographic head scan were normal.
At mediastinoscopy a lymph node biopsy was performed and the histological appearances were of angiofollicular lymph node hyperplasia consistent with Castleman's disease (Figure la, b) . She was treated with prednisolone, acetazolamide, thyroxine and hydroxycobalamin.
One year later she was readmitted on the same treatment with further weight loss and inability to walk due to progression of her peripheral neuropathy. She also complained of gradual painless blurring of vision associated with increasing headaches. She had axillary lymphadenopathy with hepatosplenomegaly, and again severe papilloedema. Her prednisolone and acetazolamide were stopped. A and was found to have an abdominal mass. Carotid angiograms were normal and cerebrospinal fluid pressure was raised. She received no specific treatment and at that time had slowly progressed over 3 years with no change in the papilloedema. In the other mentioned case6 the patient followed a relapsing course and was treated with cyclophosphamide, vincristine, procarbazine, bleomycin and prednisolone before death, but no other details were given. In our patient the pseudotumour cerebri appeared before clinical evidence of Castleman's disease, but the degree of papilloedema fluctuated with disease activity. With surgical hilar node clearance and prednisolone and chlorambucil therapy the disease and pseudotumour cerebri have remained stable for 5 years.
Note added in proof
She has recently been admitted with bone pain, apparently due to infiltration of the ribs, and so the disease is probably now progressing. 
